IGF2BP2 and early-onset autosomal dominant Alzheimer disease: To date, our knowledge for the effects of Igf2bps as m6A readers in the brain is almost blank, except for a bioinformatics study that found Igf2bp2 up-regulation in Alzheimer’s disease patient brain samples and identified multiple predicted targets of Igf2bp2 (19).